Table 3 Chi-square analysis of health-related factors by TCAM use category
Variables | TCAM use | p-value (χ2) | |
|---|---|---|---|
Yes (N = 106) | No (N = 314) | ||
HIV type | 0.985 | ||
Type 1 | 103(97.2%) | 305(97.1%) | |
Type 2 | 3(2.8%) | 9(2.9%) | |
Duration of HIV diagnosis | 0.769 | ||
< 5 years | 25(23.6%) | 70(22.2%) | |
5–10 years | 40(37.7%) | 110(35%) | |
> 10 years | 41(38.7%) | 134(42.8%) | |
Duration on ART | 0.906 | ||
< 5 years | 25(23.6%) | 70(22.2%) | |
5–10 years | 38(35.8%) | 109(34.7%) | |
> 10 years | 43(40.6%) | 135(43.1%) | |
HIV viral load | 0.154 | ||
\(\:\le\:\)1000cp/ml | 97(91.5%) | 299(95.2%) | |
> 1000cp/ml | 9(8.5%) | 15(4.8%) | |
Comorbidity | 0.653 | ||
Yes | 26(24.5%) | 84(26.8%) | |
No | 80(75.5%) | 230(73.2%) | |
ART adherence rate | 0.355 | ||
\(\:\le\:\)95% | 29(27.4%) | 101(32.2%) | |
> 95% | 77(72.6%) | 213(67.8%) | |
ART Regimen | 0.886 | ||
NNRTI-based | 83(78.3%) | 238(75.8%) | |
INSTI-based | 17(16%) | 57(18.2%) | |
PI-based | 6(5.7%) | 19(6%) | |